Company intelligence / Profile preview

Innox Pharma

Mahwah, New Jersey, USAinnoxpharma.com ↗
Ownership
Private
Employees
~50
Development stage
Preclinical
01

Overview

No specific clinical trial data or results were provided. The company highlights its commitment to quality control from early drug development stages and aims to bring effective botanical products benefiting from favorable FDA guidance.

Therapeutic areas
OncologyNeurologyHematology
Modalities
Botanical Drug Products (multicomponent, multitargeted therapies)Small molecules implied through botanical extracts but no monoclonal antibodies or advanced biologics explicitly mentioned
Industry
Biotech
02

Drug pipeline

5 assets

INN-04-01

4

4 more assets in the full pipeline.

Beyond the preview

Go deeper on Innox Pharma.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Innox Pharma.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call